… and in at least one parotid gland for 91% of the … IMRT patients. Additional benefits of using
adaptive radiotherapy to further reduce parotid dose (replanning during the course of IMRT …

… -2 M0 head and neck cancer, with parotid gland sparing IMRT or conventional bilateral neck
irradiation to a dose of at least 60 Gy, who were progression free and had no disseminated …

… In the present study, IMRT reduced the radiation dose to the parotid glands in patients with
… a sparing of salivary function. Although the mean dose to the contralateral parotid gland was …

… changes of PGs during a course of IMRT for head and neck carcinoma in patients enrolled in
… proven head and neck cancer and treated with definitive IMRT, were enrolled in this study. …

… On the other hand, absolute parotid gland volumes can vary sig… in parotid gland function
and parotid gland recovery as a function of absolute volume and dose levels after IMRT for head …

… -rated xerostomia after chemo-IMRT, with OC doses remaining … spare all the salivary glands
by IMRT, beyond the PGs alone. … study of IMRT concurrent with chemotherapy for head-and-…

… Data of 168 parotid glands of 84 patients from three Institutions treated for different Head
and neck cancer were pooled. Median patient’s age was 59 years (range: 29–86 years). Most …

… ) were treated with definitive IMRT-SIB and concomitant chemotherapy. … IMRT by recalculating
and obtaining dose-volume histograms of re-contoured target volumes and parotid glands …

Purpose To investigate the correct time point for re-planning by evaluating dosimetric changes
in the parotid glands (PGs) during intensity-modulated radiotherapy (IMRT) in head and …

… position of parotid glands during a fractionated course of image-guided IMRT for head and
neck … , and to estimate if these changes have an impact on the dose received by these glands. …